Percutaneous Microwave Ablation versus Cryoablation for Small Renal Masses (≤4 cm): 12-Year Experience at a Single Center

医学 低温消融 微波消融 单中心 经皮 烧蚀 放射科 核医学 外科 内科学
作者
George Sun,John Robert Eisenbrey,Amanda R. Smolock,Costas D. Lallas,Kevin Anton,Robert D. Adamo,Colette M. Shaw
出处
期刊:Journal of Vascular and Interventional Radiology [Elsevier BV]
卷期号:35 (6): 865-873 被引量:10
标识
DOI:10.1016/j.jvir.2024.02.005
摘要

-Cryoablation and microwave ablation both provided high technical success and local disease control of cT1a (≤4cm) small renal masses with no significant impact on renal function -Cryoablation lesions at our institution were significantly larger and of greater complexity but cancer specific survival was comparable between the two modalities -Microwave ablation and cryoablation can be viewed as complementary technologies in the kidney, with a lean towards treating smaller, less complex lesions with microwave ablation and larger, more complex lesions with cryoablation Purpose To determine whether microwave ablation (MWA) has equivalent outcomes to cryoablation (CA) in terms of technical success, adverse events, local tumor recurrence and survival in adult patients with solid enhancing renal masses ≤ 4 cm. Materials and Methods A retrospective review of 279 small renal masses (≤ 4cm) in 257 patients (median age: 71 years; range: 40-92) treated with either CA (n=191) or MWA (n=88) between January 2008 and December 2020 at a single, high-volume institution. Evaluations of adverse events, treatment effectiveness, and therapeutic outcomes were conducted for both MWA and CA. Disease-free, metastatic-free, and cancer-specific survival rates were tabulated. The estimated glomerular filtration rate (eGFR) was employed to examine treatment-related alterations in renal function. Results No difference in patient age (p=0.99) or sex (p=0.06) was observed between the MWA and CA groups. Cryoablated lesions were larger (p<0.01) and of greater complexity (p=0.03). The technical success rate for MWA was 100%, whilst one of 191 cryoablated lesions required retreatment for residual tumor. There was no impact on renal function following CA (p=0.76) or MWA (p=0.49). Secondary analysis using propensity score matching demonstrated no significant differences in local recurrence rates (p=0.39), adverse event rates (p=0.20), cancer free survival (p=0.76), or overall survival (p=0.19) when comparing matched cohorts of patients who underwent MWA and CA. Conclusion High technical success and local disease control were achieved for both MWA and CA. Cancer-specific survival was equivalent. Higher adverse event rates following CA may reflect the tendency to treat larger, more complex lesions with CA. To determine whether microwave ablation (MWA) has equivalent outcomes to cryoablation (CA) in terms of technical success, adverse events, local tumor recurrence and survival in adult patients with solid enhancing renal masses ≤ 4 cm. A retrospective review of 279 small renal masses (≤ 4cm) in 257 patients (median age: 71 years; range: 40-92) treated with either CA (n=191) or MWA (n=88) between January 2008 and December 2020 at a single, high-volume institution. Evaluations of adverse events, treatment effectiveness, and therapeutic outcomes were conducted for both MWA and CA. Disease-free, metastatic-free, and cancer-specific survival rates were tabulated. The estimated glomerular filtration rate (eGFR) was employed to examine treatment-related alterations in renal function. No difference in patient age (p=0.99) or sex (p=0.06) was observed between the MWA and CA groups. Cryoablated lesions were larger (p<0.01) and of greater complexity (p=0.03). The technical success rate for MWA was 100%, whilst one of 191 cryoablated lesions required retreatment for residual tumor. There was no impact on renal function following CA (p=0.76) or MWA (p=0.49). Secondary analysis using propensity score matching demonstrated no significant differences in local recurrence rates (p=0.39), adverse event rates (p=0.20), cancer free survival (p=0.76), or overall survival (p=0.19) when comparing matched cohorts of patients who underwent MWA and CA. High technical success and local disease control were achieved for both MWA and CA. Cancer-specific survival was equivalent. Higher adverse event rates following CA may reflect the tendency to treat larger, more complex lesions with CA.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yyy完成签到,获得积分10
刚刚
刚刚
大模型的应助被hxhdh采纳,获得10
刚刚
Lucas的应助被小羊采纳,获得10
1秒前
小巧皮卡丘完成签到,获得积分10
1秒前
酷波er的应助被Mnjr采纳,获得10
1秒前
1秒前
学术渣滓发布了新的文献求助10
2秒前
时尚面包完成签到,获得积分10
2秒前
2秒前
2秒前
敏er好学完成签到,获得积分10
2秒前
bkagyin的应助被DAI采纳,获得10
3秒前
野草完成签到,获得积分10
3秒前
2226发布了新的文献求助10
3秒前
华仔的应助被烟雨平生采纳,获得10
3秒前
LL完成签到 ,获得积分10
4秒前
4秒前
jbq发布了新的文献求助10
4秒前
游志涛发布了新的文献求助10
4秒前
4秒前
Qin完成签到,获得积分20
4秒前
drx66完成签到,获得积分10
4秒前
4秒前
5秒前
科目三的应助被yy采纳,获得10
5秒前
能干秋珊发布了新的文献求助10
5秒前
科研通AI6.4的应助被飞翔868采纳,获得10
5秒前
深情安青的应助被lilyswift采纳,获得10
6秒前
6秒前
molihuakai的应助被出岫采纳,获得10
6秒前
6秒前
南京市民的应助被xucc采纳,获得50
6秒前
仓鼠香香完成签到,获得积分10
7秒前
王灿然发布了新的文献求助10
7秒前
7秒前
共享精神的应助被SolitarySnow采纳,获得10
7秒前
思思思颖完成签到,获得积分10
8秒前
dog发布了新的文献求助10
8秒前
杨启军完成签到,获得积分20
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177018
求助须知:如何正确求助?哪些是违规求助? 9568115
关于积分的说明 21796984
捐赠科研通 7771640
什么是DOI,文献DOI怎么找? 3432240
关于科研通互助平台的介绍 2556496
邀请新用户注册赠送积分活动 2477766